Cocrystal Pharma, Inc. (COCP)
Develops antiviral drugs to treat influenza, coronavirus, and hepatitis C infections.
$0.92+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-50.3%
The outlook
COCP is trading near its 52-week low, well below both short and long-term moving averages. Analyst coverage is sparse, but the average price target sits significantly above the current price. Overall sentiment leans bearish, reflecting the stock's weak technical position.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +878% vs current price
Analyst price target
~12-month · 2 analysts$9.00average target+878.3% vs now
Now $0.92
Low $8.00High $10.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$12.7M
52-wk high
$2.67
52-wk low
$0.86
50-day avg
$1.03
200-day avg
$1.09
Trailing P/E
—